These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15777568)

  • 21. [EEG changes under sodium diethyldithiocarbamate therapy in 2 cases of Wilson's disease].
    Lang HD; Reichenmiller HE; Tigges FJ; Braun HJ; Golisch G
    Med Klin; 1972 Jun; 67(26):916-21. PubMed ID: 5048687
    [No Abstract]   [Full Text] [Related]  

  • 22. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wilson's disease patients can be decoppered.
    Walshe JM
    Lancet; 1989 Jul; 2(8656):228. PubMed ID: 2568563
    [No Abstract]   [Full Text] [Related]  

  • 24. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
    Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
    J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Wilson's disease and secondary copper hemochromatoses in hematological practice].
    Vorob'ev AI; Lukina EA; Sysoeva EP; Levina AA; Solov'eva TI
    Ter Arkh; 2004; 76(7):55-9. PubMed ID: 15379129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wilson's disease and pregnancy.
    Sternlieb I
    Hepatology; 2000 Feb; 31(2):531-2. PubMed ID: 10655282
    [No Abstract]   [Full Text] [Related]  

  • 28. Patient with late-onset Wilson's disease: deterioration with penicillamine.
    Sohtaoglu M; Ergin H; Ozekmekçi S; Gökdemir S; Sonsuz A; Arici C
    Mov Disord; 2007 Jan; 22(2):290-1. PubMed ID: 17083099
    [No Abstract]   [Full Text] [Related]  

  • 29. A copper for your thoughts.
    Coates RA
    J Insur Med; 2012; 43(2):112-5. PubMed ID: 22876415
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of penicillamine nephropathy in Wilson's disease: a new chelating agent.
    Walshe JM
    Lancet; 1969 Dec; 2(7635):1401-2. PubMed ID: 4188283
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
    Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychosis and Wilson's disease: a case report.
    Jukić I; Titlić M; Tonkić A; Dodig G; Rogosić V
    Psychiatr Danub; 2006 Jun; 18(1-2):105-7. PubMed ID: 16804509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tracing copper-thiomolybdate complexes in a prospective treatment for Wilson's disease.
    Zhang L; Lichtmannegger J; Summer KH; Webb S; Pickering IJ; George GN
    Biochemistry; 2009 Feb; 48(5):891-7. PubMed ID: 19146437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cold comfort pharm.
    Will RG
    Pract Neurol; 2008 Feb; 8(1):60-1. PubMed ID: 18230710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Axonal sensory motor neuropathy in copper-deficient Wilson's disease.
    Foubert-Samier A; Kazadi A; Rouanet M; Vital A; Lagueny A; Tison F; Meissner W
    Muscle Nerve; 2009 Aug; 40(2):294-6. PubMed ID: 19609919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute recurrent hemolytic anemia as the first manifestation of Wilson's disease: Report of a case].
    El Khattabi A; Seddik H; Fatihi J; Salaheddine H; Badaoui M; Amézyane T; Mahassine F; Ohayon V
    Transfus Clin Biol; 2009 Mar; 16(1):39-42. PubMed ID: 19329346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and biological study of a case of Wilson's disease in pure hepatic form in an infant; favorable effects of therapy with chelating agents].
    FRANCOIS R; LARBRE F; NICOLAS A; MALLEIN R; RUITTON-UGLIENGO
    Minerva Pediatr; 1959 Mar; 11(13):390-6. PubMed ID: 13656852
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical and biological study of Wilson's disease with pure hepatic form in an infant; successful results of therapy with chelating agents].
    FRANCOIS R; LARBRE F; NICOLAS A; MALLEIN R; RUITTON-UGLIENGO ; DESCROIX
    Pediatrie; 1959; 14(3):279-91. PubMed ID: 13667351
    [No Abstract]   [Full Text] [Related]  

  • 39. [Late presentation of Wilson's disease].
    Santander Vaquero C
    Rev Esp Enferm Dig; 2002 Aug; 94(8):502-3. PubMed ID: 12486857
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neurological complications of Wilson's disease].
    Burgos A; Bermejo PE
    Med Clin (Barc); 2011 Oct; 137(9):419-23. PubMed ID: 21596401
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.